Citigroup
CELL

Citigroup’s PhenomeX Inc. Common Stock CELL Stock Holding History

Citigroup’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-90,000
Closed -$1.76M – 6158
2021
Q3 		$1.76M Buy
+90,000
New +$3.42M ﹤0.01% 2636

Other funds holding CELL

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
NIMC
Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citigroup's CELL Position: Q2 2023 in Review

Citigroup sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 1,963 shares — an estimated $2.28K sold.

Citigroup first reported a position in CELL in Q3 2020 and held it in 11 quarters. The position peaked at $4.56M in Q1 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Citigroup reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Citigroup sold 1,963 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $2.28K.
  • Citigroup first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • Citigroup's PhenomeX Inc. Common Stock position peaked at $4.56M in Q1 2021.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Citigroup's 13F filing for Q2 2023, filed 10 Aug 2023.